Risk Factors for and Pre-Medications to Prevent Cetuximab-Induced Infusion Reactions in Patients With Squamous Cell Carcinoma of the Head and Neck

Oral Oncology - United Kingdom
doi 10.1016/j.oraloncology.2014.06.017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck

American Journal of Clinical Oncology: Cancer Clinical Trials
Cancer ResearchOncology
2016English

Socioeconomic Factors and Survival in Patients With Non-Metastatic Head and Neck Squamous Cell Carcinoma

Cancer Science
Cancer ResearchMedicineOncology
2017English

Periodontal Disease and Mouthwash Use Are Risk Factors for Head and Neck Squamous Cell Carcinoma

Cancer Causes and Control
Cancer ResearchOncology
2013English

Analysis of Selected Risk Factors for Nodal Metastases in Head and Neck Cutaneous Squamous Cell Carcinoma

European Archives of Oto-Rhino-Laryngology
MedicineOtorhinolaryngology
2014English

Nicotine Promotes Lymph Node Metastasis and Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma

International Journal of Oncology
Cancer ResearchOncology
2018English

Immunotherapy for Head and Neck Squamous Cell Carcinoma

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

Recent Results of Cetuximab Use in the Treatment of Squamous Cell Carcinoma of the Head and Neck

OncoTargets and Therapy
OncologyPharmacology
2009English

Genetic Variants in Selected Pre-microRNA Genes and the Risk of Squamous Cell Carcinoma of the Head and Neck

Cancer
Cancer ResearchOncology
2010English

Head and Neck: Oral Squamous Cell Carcinoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy